VOR Smart Money
Vor Biopharma Inc.
1W: +2.7%
1M: +6.7%
3M: -0.1%
YTD: +67.9%
1Y: -28.1%
3Y: -56.8%
5Y: -93.9%
$19.54
+1.21 (+6.60%)
Weekly Expected Move ±7.3%
$16
$17
$18
$20
$21
Credit Risk of going bust: lower than 52% of companies Debt: 0.3% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down 99.9%), Vor Biopharma Inc. would be worth roughly what it owes.
Total debt $2.9M against a stock market value of $1.06B.
Distance to default 5.37 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.4M (short-term plus half of long-term), stock volatility 112.3%; Altman Z'' 5.08. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.01 (down 99.9%), Vor Biopharma Inc. would be worth roughly what it owes.
Total debt $2.9M against a stock market value of $1.06B.
Distance to default 5.37 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.4M (short-term plus half of long-term), stock volatility 112.3%; Altman Z'' 5.08. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026121
Institutions Holding
+31 vs prior
84.5%
Ownership
+16.78%
41
New
35
Increased
36
Reduced
17
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-16 | Shah Rajeev M. | 10% owner | S-Sale | 213 | $19.75 | $4K | Filing |
| 2026-07-16 | Kolchinsky Peter | 10% owner | S-Sale | 213 | $19.75 | $4K | Filing |
| 2026-07-16 | RA Capital Healthcare Fund LP | 10% owner | S-Sale | 213 | $19.75 | $4K | Filing |
| 2026-07-16 | RA CAPITAL MANAGEMENT, L.P. | 10% owner | S-Sale | 213 | $19.75 | $4K | Filing |
| 2026-04-22 | Shah Rajeev M. | director | S-Sale | 165,150 | $15.77 | $2.6M | Filing |
| 2026-04-22 | Kolchinsky Peter | director | S-Sale | 165,150 | $15.77 | $2.6M | Filing |
| 2026-04-22 | RA Capital Healthcare Fund LP | director | S-Sale | 165,150 | $15.77 | $2.6M | Filing |
| 2026-04-22 | RA CAPITAL MANAGEMENT, L.P. | director | S-Sale | 165,150 | $15.77 | $2.6M | Filing |
| 2026-04-20 | Shah Rajeev M. | director | S-Sale | 171,963 | $15.77 | $2.7M | Filing |
| 2026-04-20 | Kolchinsky Peter | director | S-Sale | 171,963 | $15.77 | $2.7M | Filing |
| 2026-04-20 | RA Capital Healthcare Fund LP | director | S-Sale | 171,963 | $15.77 | $2.7M | Filing |
| 2026-04-20 | RA CAPITAL MANAGEMENT, L.P. | director | S-Sale | 171,963 | $15.77 | $2.7M | Filing |
| 2026-04-17 | Shah Rajeev M. | director | S-Sale | 458,411 | $16.28 | $7.5M | Filing |
| 2026-04-17 | Kolchinsky Peter | director | S-Sale | 458,411 | $16.28 | $7.5M | Filing |
| 2026-04-17 | RA Capital Healthcare Fund LP | director | S-Sale | 458,411 | $16.28 | $7.5M | Filing |
| 2026-04-17 | RA CAPITAL MANAGEMENT, L.P. | director | S-Sale | 458,411 | $16.28 | $7.5M | Filing |
| 2026-04-15 | Shah Rajeev M. | director | S-Sale | 53,644 | $16.01 | $859K | Filing |
| 2026-04-15 | Kolchinsky Peter | director | S-Sale | 53,644 | $16.01 | $859K | Filing |
| 2026-04-15 | RA Capital Healthcare Fund LP | director | S-Sale | 53,644 | $16.01 | $859K | Filing |
| 2026-04-15 | RA CAPITAL MANAGEMENT, L.P. | director | S-Sale | 53,644 | $16.01 | $859K | Filing |
| 2026-04-14 | RA Capital Healthcare Fund LP | director | S-Sale | 153,735 | $15.97 | $2.5M | Filing |
| 2026-04-14 | Shah Rajeev M. | director | S-Sale | 153,735 | $15.97 | $2.5M | Filing |
| 2026-04-14 | Kolchinsky Peter | director | S-Sale | 153,735 | $15.97 | $2.5M | Filing |
| 2026-04-14 | RA CAPITAL MANAGEMENT, L.P. | director | S-Sale | 153,735 | $15.97 | $2.5M | Filing |
| 2026-04-13 | Shah Rajeev M. | director | S-Sale | 530,610 | $16.15 | $8.6M | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 5,673,078 | $104M | — | 2026-06-30 | Filing |
| FMR LLC | 4,932,149 | $91M | +3,392,479 | 2026-06-30 | Filing |
| FCPM III SERVICES B.V. | 4,117,354 | $76M | — | 2026-06-30 | Filing |
| BlackRock, Inc. | 3,468,107 | $64M | +2,673,348 | 2026-06-30 | Filing |
| Venrock Adviser, LLC | 3,041,719 | $56M | — | 2026-06-30 | Filing |
| STATE STREET CORP | 2,616,336 | $48M | +1,497,878 | 2026-06-30 | Filing |
| Frazier Life Sciences Management, L.P. | 2,543,939 | $47M | — | 2026-06-30 | Filing |
| RA CAPITAL MANAGEMENT, L.P. | 2,402,095 | $44M | -3,002,903 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,084,328 | $38M | +651,048 | 2026-06-30 | Filing |
| Caligan Partners LP | 1,925,066 | $35M | — | 2026-06-30 | Filing |
| Paradigm Biocapital Advisors LP | 1,750,000 | $32M | — | 2026-06-30 | Filing |
| GREAT POINT PARTNERS LLC | 1,700,000 | $31M | -50,000 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,062,469 | $20M | +719,896 | 2026-06-30 | Filing |
| NEXTBio Capital Management LP | 889,164 | $16M | -110,803 | 2026-06-30 | Filing |
| Nantahala Capital Management, LLC | 845,000 | $16M | +845,000 | 2026-06-30 | Filing |
| ADAR1 Capital Management, LLC | 680,626 | $13M | +680,626 | 2026-06-30 | Filing |
| Logos Global Management LP | 650,000 | $12M | -100,000 | 2026-06-30 | Filing |
| Rosalind Advisors, Inc. | 648,600 | $12M | -51,400 | 2026-06-30 | Filing |
| NAN FUNG TRINITY (HK) LTD | 646,550 | $12M | +646,550 | 2026-06-30 | Filing |
| BRAIDWELL LP | 573,104 | $11M | +106,330 | 2026-06-30 | Filing |